Deregulated c-Myc expression has been associated with cancer, metabolic and inflammatory conditions (Zheng et al., 2017; Luo et al., 2021; Rosselot et al., 2021; Nevzorova and Cubero, 2023; Zacarias-Fluck et al., 2024). Here, MYC is linked to cancer.